The FDA Grants Premarket Approval To United Therapeutics' LungFX Device For Use In Centralized Ex Vivo Lung Perfusion, A Procedure That Enables Donor Lungs To Be Assessed Outside The Body After Procurement And Before Transplantation

Loading news article.

The FDA Grants Premarket Approval To United Therapeutics' LungFX Device For Use In Centralized Ex Vivo Lung Perfusion, A Procedure That Enables Donor Lungs To Be Assessed Outside The Body After Procurement And Before Transplantation | WAPE

The FDA Grants Premarket Approval To United Therapeutics' LungFX Device For Use In Centralized Ex Vivo Lung Perfusion, A Procedure That Enables Donor Lungs To Be Assessed Outside The Body After Procurement And Before Transplantation

Article summary

Related companies

Comments —